April brings more than just showers – the month kicks off with a very important cancer research conference. Tomorrow we are headed to Washington, DC for the American Association for Cancer Research (AACR) annual meeting held April 1-5, 2017.
Our team will be joining approximately 20,000 cancer researchers from across the country and around the world for this important meeting. Several physicians and scientists from Weill Cornell Medicine, NewYork-Presbyterian, and the Meyer Cancer Center again served on the scientific program committee, including our own Dr. Scott Tagawa.
We’re also proud that Dr. Bishoy Faltas was selected as an AACR NextGen Star, a competitive award that supports professional development and advancement for scientists who are early in their career. Dr. Faltas will be presenting important updates related to bladder cancer, and his NextGen Star talk will take place on Wednesday, April 5, and is titled Genomic dissection of the clonal evolution dynamics of chemotherapy-resistant urothelial carcinoma.
We have a lot to share at AACR 2017, so please check back frequently as we’ll be updating the blog regularly throughout the week.
Here are some additional highlights of what’s to come:
- Updates regarding circulating tumor cells (CTCs) and the role of biomarkers in non-invasive diagnostics and treatments
- How organoids may help us better treat neuroendocrine prostate cancer (NEPC)
- The different types of radiation used to treat prostate cancer and how we’re targeting PSMA – a marker on the surface of most prostate cancer cells – with radioimmunotherapy to kill cancer cells
- The latest updates in bladder cancer research, including updates in genomics and targeting molecular pathways